We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Q&A WITH BARR PHARMA'S CHIEF BRUCE DOWNEY, PART TWO
Q&A WITH BARR PHARMA'S CHIEF BRUCE DOWNEY, PART TWO
November 2, 2004
Generic Line interviewed Bruce Downey, chairman and CEO of Barr Pharmaceuticals, a specialty company engaged in the development, manufacture, and marketing of proprietary and generic prescription pharmaceuticals.